AOD-9604 5mg

£21.99

XL Peptides works with various third-party laboratories to provide testing reports for all its manufactured products.

Date	Batch No	Issuing Lab	Lab Report	View QR
11-Mar-26	10000023712-5		View Report

To find out more about our testing policy, please visit our Testing page.

Category: Peptides

Description
Reviews (0)

AOD-9604 is a research peptide derived from the C-terminal region of human growth hormone, used in controlled in-vitro studies of peptide pharmacology, receptor-adjacent signalling, and assay development under non-clinical laboratory conditions.

AOD-9604 — 5 mg | Research Use Only

This listing provides a 5 mg vial of AOD-9604 for cell-based and biochemical model systems. Investigations focus on molecular mechanisms and assay readouts only.
For laboratory research only. Not for human use.

Key features

hGH-derived research peptide for in-vitro signalling/SAR investigations.
Supplied as a lyophilised solid for stability and straightforward storage.
Unit size: 5 mg per vial.
Each batch released after stringent internal quality checks.

Specifications for AOD-9604

Product name: AOD-9604
Synonyms: hGH fragment analogue; C-terminal hGH peptide
Class: Peptide fragment/analogue (research use)
Form: Lyophilised powder
Appearance: White to off-white solid
Note: Salt/counter-ion and hydration state may vary. Refer to the vial label for lot-specific details.

Handling & storage of AOD-9604

Storage (dry): Keep vials at 2–8 °C, protected from light and moisture.
Reconstitution: For step-by-step guidance, see our internal guide:
Reconstituting & Storage.
After reconstitution: Store at 2–8 °C, protect from light, use aliquots to reduce handling, and avoid repeated temperature cycling.
Compatibility: Use only within research protocols that follow your lab’s SOPs and local regulations.

Important: Free empty 10 ml vial included (AOD-9604 is gel-prone)

Every AOD-9604 order includes a free empty 10 ml vial. AOD-9604 can be gel-prone at higher concentrations. For best laboratory handling, we recommend preparing a minimum total volume of 5 ml after reconstitution to reduce the chance of gelling.

Step 1: Reconstitute AOD-9604 in the original peptide vial with 2 ml of diluent.
Step 2: Transfer the solution to the included empty 10 ml vial.
Step 3: Add additional diluent to reach a minimum total volume of 5 ml.

Note: If AOD-9604 is reconstituted into too small a volume, it may gel, particularly with high-purity material.

Looking for complementary materials? See the guide above and related GH-axis research peptides such as
HGH-Frag (176–191) 5 mg,
CJC-1295 (No DAC) 5 mg, and
Ipamorelin 5 mg.

About AOD-9604 in research

Researchers use AOD-9604 to examine peptide fragment analogues in model systems, profile downstream second-messenger responses, and compare structure–activity relationships alongside other GH-axis reagents. All studies occur exclusively in controlled, non-clinical in-vitro environments.

Synthesis & quality

Manufactured via controlled, validated peptide-synthesis processes to deliver high purity and lot-to-lot consistency. Each batch undergoes identity, purity, and appearance checks before release.

Legal & safety

XL Peptides supplies materials strictly for laboratory research. Products are not medications, foods, supplements, or cosmetics; not for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will handle the material in line with your institution’s policies and applicable laws.

FAQs about AOD-9604

Why is an empty 10 ml vial included?
AOD-9604 can be gel-prone at higher concentrations. The empty 10 ml vial supports preparation at a higher total volume (minimum 5 ml) for improved handling in research workflows.

Where can I find reconstitution guidance?
See our step-by-step internal guide:
Reconstituting & Storage.

Is this product for human use?
No. This material is for research only and is not intended for human consumption or clinical applications.